Using aspirin for coronary heart prevention is less costly and more effective, found in a study.

The researchers specifically considered the effects of each treatment on cardiovascular events and risk of upper gastrointestinal bleeding.
"This analysis supports the role of aspirin for primary prevention of cardio heart disease events in middle-aged men across a range of cardio heart disease and gastrointestinal bleeding risk levels," said lead author Stephanie Earnshaw, of the RTI Health Solutions.
"Increased risk of gastrointestinal bleeding does not reduce aspirin's net benefit until gastrointestinal bleeding risk becomes quite high," she said.
The researchers also found that adding proton pump inhibitors was not cost-effective for men with average gastrointestinal tract bleeding, but may be cost-effective for selected men at increased risk for gastrointestinal bleeding.
The findings have been published in the Archives of Internal Medicine.
Advertisement